BSX - Boston Scientific Corporation Inc. Market Cap to Earnings and Growth Ratio
High competition in the medtech niche is constrained by patents, yet the strong engineering talent pool at Boston Scientific (BSX) ensures leadership. The valuation-to-growth ratio helps correlate these factors, where the value 4.35 indicates the current metric. However, ultimate success depends on overcoming regulatory barriers and the risks of reduced government pricing.
%20PEG%20Multiple&width=1200&height=400&colorIndex=0&v=mwa76aez.ocr-7cpmfb4&start=20220704&end=20261110&filename=GURU_Markets_-_BSX_-_Boston-Scientific_-_PEG-Multiple "BSX - bostonscientific.com Price to Earnings Adjusted for Growth Rate over the range 07/04/2022 - 11/10/2026 | 👁️GURU.Markets👁️")
Metric breakdowns and analytics for Boston Scientific (BSX)
- price and consensus price forecast:
- market capitalization statistics:
- balance sheet net asset value indicators:
- debt obligations and liquidity statistics:
All Debt to Shareholders' Equity Ratio Boston Scientific|BSX - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio bostonscientific.com|BSX - Company Aggregate Debts|Debts to Book Value Boston Scientific Inc|BSX - Company Long-Term Debts|Company Short-Term Indebtedness Boston Scientific|Interim Coverage Ratio bostonscientific.com
- earnings and multiples data:
BSX - Net Profit|Future Profit Boston Scientific|BSX - P/E Multiple|Forward P/E Multiple Boston Scientific Corporation Inc.|BSX - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Boston Scientific Inc|BSX - Operating profit before deduction of amortization|Earnings per share for the trailing year Boston Scientific|BSX - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months bostonscientific.com|BSX - Earnings per share growth in current year|Net earnings per one share growth forecast for next year Boston Scientific
General company analysis:BSX - Boston Scientific Corp
The PEG ratio compares the market value of earnings to their growth rate, allowing for the determination of a fair price for future business expansion and preventing overpayment for an asset. By analyzing the PEG relative undervaluation metric, an investor can confirm the effectiveness of the Boston Scientific (BSX) strategy of aggressive market capture and targeted acquisition of innovative medical technologies through the lens of real growth value.
Competing companies
Growth-Adjusted Market Cap to Net Income Edwards|ResMed Corp - Price/Earnings to Growth Multiple|PODD (Insulet Inc.) - Market Cap to Earnings and Growth Ratio|Zimmer Biomet Holdings, Inc. - PEG Multiple|Price to Earnings Adjusted for Growth Rate coopercos.com|ALGN: PEG Multiple|Growth-Adjusted P/E Ratio GMED|Price/Earnings to Growth Multiple TMDX|ATEC: Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Artivion, Inc. (AORT)|Price/Earnings to Growth Multiple enovis.com ENOV|PEG Multiple IART (Integra LifeSciences Holdings Corporation)|Establishment Labs Corp (ESTA) - Price to Earnings Adjusted for Growth Rate|Beta Bionics Corp - PEG Multiple|IRMD (IRADIMED Inc.) - Growth-Adjusted P/E Ratio|EMBC: PEG Multiple|TNDM - Growth-Adjusted Market Cap to Net Income|AXGN (Axogen) - PEG Multiple|Price/Earnings to Growth Multiple SI-BONE Inc (SIBN)|PEG Multiple OFIX|PEG Multiple Bioventus Global (BVS)|Price/Earnings to Growth Ratio OrthoPediatrics KIDS|treace.com - Price/Earnings to Growth Ratio|SRTA: Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio CARL (Carlsmed, Inc.)|RXST: PEG Multiple|Price to Earnings Adjusted for Growth Rate ClearPoint Neuro (CLPT)|Price/Earnings to Growth Ratio Stereotaxis, Inc.|STIM - Price to Net Income Growth Ratio|Price/Earnings to Growth Multiple SGHT (Sight Sciences)|PEG Multiple Orchestra BioMed Inc. (OBIO)|PEG Multiple ANIK (Anika Therapeutics, Inc.)|Growth-Adjusted Market Cap to Net Income InspireMD Inc. (NSPR)|ZJYL - Price/Earnings to Growth Ratio|Market Cap to Earnings and Growth Ratio VANI|xtantmedical.com (XTNT) - Price/Earnings to Growth Ratio|Price/Earnings to Growth Multiple NeuroOne|MODD (Modular Medical Inc) - PEG Multiple|Price to Earnings Adjusted for Growth Rate Myomo Inc MYO|Price/Earnings to Growth Ratio Envoy Medical, Inc. (COCH)|vivoslife.com - Growth-Adjusted P/E Ratio|enVVeno Medical Corp. - Price/Earnings to Growth Multiple|Company Value to Earnings Growth Ratio SINT (Sintx Technologies Inc)|Tenon Medical, Inc - PEG Multiple|LFWD: Price/Earnings to Growth Ratio|autonomix.com (AMIX) - Price/Earnings to Growth Ratio|Price to Earnings Adjusted for Growth Rate invobioscience.com (IVF)|Price/Earnings to Growth Ratio Bone Biologics Corp|Axonics Inc. (AXNX) - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Multiple BIOL (Biolase, Inc.)|Company Value to Earnings Growth Ratio DYNT|Price/Earnings to Growth Ratio Paragon 28 FNA|INVO Bioscience Inc. (INVO) - Price to Earnings Adjusted for Growth Rate
